Amanote Research
Register
Sign In
P.060 Time to Treatment Effect in Spinal Muscular Atrophy Type 1 (SMA1): An Indirect Comparison of Treatments
Canadian Journal of Neurological Sciences
- United Kingdom
doi 10.1017/cjn.2019.160
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Neurology
Date
June 1, 2019
Authors
RS Finkel
O Dabbous
R Arjunji
M Droege
DE Feltner
A Novack
M Menier
DM Sproule
Publisher
Cambridge University Press (CUP)
Related search
Spinal Muscular Atrophy Type 1
Pediatric Critical Care Medicine
Child Health
Critical Care
Pediatrics
Perinatology
Intensive Care Medicine
Current and Future Treatments of Spinal Muscular Atrophy
Developmental Medicine and Child Neurology
Child Health
Developmental Neuroscience
Pediatrics
Perinatology
Neurology
066 Avxs-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Spinal Muscular Atrophy: Development and Implementation of Potential Treatments
Annals of Neurology
Neurology
Who Influences Parents’ Decision on Life Support Treatments for Children With Spinal Muscular Atrophy Type 1?
Pediatric Dimensions
Respiratory Management of the Infant With Type 1 Spinal Muscular Atrophy
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Healthcare Resource Use (HRU) in Hospitalized Patients With a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Operative Treatment for Hip Subluxation in Spinal Muscular Atrophy
The Journal of Bone and Joint Surgery. British volume
Spinal Muscular Atrophy With Respiratory Distress Type 1—A Child With Atypical Presentation
Child Neurology Open
